You need to create a user account to read this article.
With a subscription you unlock more content on BioStock.
ESMO 2025: mRNA vaccine boosts checkpoint inhibitors
Text:
Tommie Anderberg | [email protected]
Cancer patients who received mRNA-based COVID vaccines within 100 days of starting immunotherapy had twice the chance of surviving three years after starting treatment as unvaccinated patients. This shows...